Get to know PIQRAY

The first and only treatment with fulvestrant specifically for postmenopausal women, and men, with a PIK3CA mutation in HR+, HER2- metastatic breast cancer whose disease has progressed on or after endocrine (hormone) therapy.

Important Safety Information:

Do not take PIQRAY if you have had a severe allergic reaction to PIQRAY or are allergic to any of the ingredients in PIQRAY.

PIQRAY may cause serious side effects, including:

  • Severe allergic reactions:...

See More
Approved Use:

PIQRAY is a prescription medicine used in combination with the medicine fulvestrant to treat women who have gone through menopause, and men:

  • who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer or breast cancer that ha...
See More
Learn more

I am talking to my doctor about PIQRAY

Advocating for yourself starts with being informed. Here are some resources to help you and your doctor choose a treatment specifically for your type of metastatic breast cancer.


Get support

I am taking PIQRAY

Explore these resources and support programs to help you on your treatment journey with PIQRAY: